Regulatory B cells present in lymph nodes draining a murine tumor [Separata] /

In cancer, B cells have been classically associated with antibody secretion, antigen presentation and T cell activation. However, a possible role for B lymphocytes in impairing antitumor response and collaborating with tumor growth has been brought into focus. Recent reports have described the capac...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Maglioco, Andrea
Otros Autores: Machuca, Damian G., Camerano, Gabriela V., Costa, Héctor, Ruggiero, Raúl A., Dran, Graciela I.
Formato: Capítulo de libro
Lenguaje:Inglés
Materias:
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 02649naa a2200313 a 4500
003 AR-BaFLA
008 191113t2013 ag d|||fs|||| 00| 0 eng d
999 |c 46715  |d 46715 
037 |n Depósito reglamentario 
040 |a FLACSO Argentina  |c FLACSO Argentina 
041 0 |a eng 
100 1 |9 33509  |a Maglioco, Andrea 
245 1 0 |a Regulatory B cells present in lymph nodes draining a murine tumor [Separata] /   |c Andrea Maglioco ...[y otros]  |h DIG 
300 |a pp. 185-188  |b diagrs. 
336 |2 rdacontent  |a Texto  |b txt 
337 |2 rdamedia  |a computadora  |b c 
338 |2 rdacarrier  |a Recurso el línea  |b cr 
504 |a incl. ref. 
520 |a In cancer, B cells have been classically associated with antibody secretion, antigen presentation and T cell activation. However, a possible role for B lymphocytes in impairing antitumor response and collaborating with tumor growth has been brought into focus. Recent reports have described the capacity of B cells to negatively affect immune responses in autoimmune diseases. The highly immunogenic mouse tumor MCC loses its immunogenicity and induces systemic immune suppression and tolerance as it grows. We have previously demonstrated that MCC growth induces a distinct and progressive increase in B cell number and proportion in the tumor draining lymph nodes (TDLN), as well as a less prominent increase in T regulatory cells. The aim of this research was to study B cell characteristics and function in the lymph node draining MCC tumor and to analyze whether these cells may be playing a role in suppressing antitumor response and favoring tumor progression. Results indicate that B cells from TDLN expressed increased CD86 and MHCII co-stimulatory molecules indicating activated phenotype, as well as intracellular IL-10, FASL and Granzyme B, molecules with regulatory immunosuppressive properties. Additionally, B cells showed high inhibitory upon T cell proliferation ex vivo, and a mild capacity to secrete antibodies. Our conclusion is that even when evidence of B cell-mediated activity of the immune response is present, B cells from TDLN exhibit regulatory phenotype and inhibitory activity, probably contributing to the state of immunological tolerance characteristic of the advanced tumor condition. 
650 4 |9 2776  |a  INVESTIGACION MEDICA 
650 4 |9 5723  |a CANCER 
690 |a SALUD 
700 1 |9 33510  |a Machuca, Damian G. 
700 1 |9 33513  |a Camerano, Gabriela V. 
700 1 |9 33514  |a Costa, Héctor 
700 1 |9 33516  |a Ruggiero, Raúl A. 
700 1 |9 33518  |a Dran, Graciela I. 
773 0 |d Buenos Aires : Fundación Revista Medicina, 2013  |t Medicina  |x 1669-9106 
942 |c ART